{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:26:23Z","timestamp":1774020383742,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.leukres.2010.09.001","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T13:35:53Z","timestamp":1287495353000},"page":"472-478","source":"Crossref","is-referenced-by-count":9,"title":["In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"35","author":[{"given":"Gudmar","family":"L\u00f6nnerholm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Th\u00f6rn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christer","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britt-Marie","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trond","family":"Flaegstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olafur Gisli","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arja","family":"Harila-Saari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans O.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Porwit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"S\u00f6derh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn","family":"Wesenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Vettenranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.leukres.2010.09.001_bib0005","first-page":"S121","article-title":"Evolution of BFM trials for childhood ALL","volume":"83","author":"Schrappe","year":"2004","journal-title":"Ann Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2010.09.001_bib0010","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","article-title":"Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome","volume":"99","author":"Nyvold","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2010.09.001_bib0015","first-page":"382","article-title":"Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology","volume":"90","author":"Cazzaniga","year":"2005","journal-title":"Haematologica"},{"issue":"9142","key":"10.1016\/j.leukres.2010.09.001_bib0020","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.leukres.2010.09.001_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.seminhematol.2008.09.001","article-title":"Minimal residual disease in acute lymphoblastic leukemia","volume":"46","author":"Campana","year":"2009","journal-title":"Semin Hematol."},{"issue":"26","key":"10.1016\/j.leukres.2010.09.001_bib0030","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.leukres.2010.09.001_bib0035","first-page":"24","article-title":"Standardized MRD quantification in European ALL trials","volume":"24","author":"Bruggemann","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.09.001_bib0040","doi-asserted-by":"crossref","unstructured":"Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grumayer R, Moricke A, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood; 2010: 12.","DOI":"10.1182\/blood-2009-10-248146"},{"issue":"9","key":"10.1016\/j.leukres.2010.09.001_bib0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer\u2013Childhood Leukemia Cooperative Group","volume":"339","author":"Cave","year":"1998","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1016\/j.leukres.2010.09.001_bib0050","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2006-09-045369","article-title":"Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01","volume":"110","author":"Zhou","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2010.09.001_bib0055","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V90.7.2723","article-title":"In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia","volume":"90","author":"Kaspers","year":"1997","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2010.09.001_bib0060","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1182\/blood.V89.8.2959","article-title":"In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia","volume":"89","author":"Hongo","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2010.09.001_bib0065","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2141.2003.04442.x","article-title":"Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia","volume":"122","author":"Frost","year":"2003","journal-title":"Br J Haematol"},{"issue":"17","key":"10.1016\/j.leukres.2010.09.001_bib0070","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2003.11.031","article-title":"Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia","volume":"21","author":"Den Boer","year":"2003","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2010.09.001_bib0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.leu.2403540","article-title":"Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia","volume":"19","author":"Frost","year":"2005","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.leukres.2010.09.001_bib0080","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2003-12-4426","article-title":"Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia","volume":"104","author":"Frost","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2010.09.001_bib0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/leu.2008.179","article-title":"Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids","volume":"23","author":"Lonnerholm","year":"2009","journal-title":"Leukemia."},{"issue":"4","key":"10.1016\/j.leukres.2010.09.001_bib0090","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1046\/j.1365-2141.2002.36211.x","article-title":"Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?","volume":"118","author":"De Haas","year":"2002","journal-title":"Br J Haematol."},{"issue":"7","key":"10.1016\/j.leukres.2010.09.001_bib0095","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.leu.2402144","article-title":"Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance","volume":"15","author":"Schmiegelow","year":"2001","journal-title":"Leukemia."},{"issue":"1","key":"10.1016\/j.leukres.2010.09.001_bib0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.leukres.2008.06.012","article-title":"In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia","volume":"33","author":"Lonnerholm","year":"2009","journal-title":"Leuk Res."},{"issue":"11","key":"10.1016\/j.leukres.2010.09.001_bib0105","first-page":"1121","article-title":"Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia","volume":"6","author":"Nygren","year":"1992","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.leukres.2010.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0959-8049(05)80316-8","article-title":"Laboratory prediction of clinical chemotherapeutic drug resistance: a working model exemplified by acute leukaemia","volume":"29A","author":"Larsson","year":"1993","journal-title":"Eur J Cancer"},{"issue":"9583","key":"10.1016\/j.leukres.2010.09.001_bib0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.leukres.2010.09.001_bib0120","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.09.001_bib0125","series-title":"An International System for Human Cytogenetic Nomenclature","year":"1995"},{"issue":"3","key":"10.1016\/j.leukres.2010.09.001_bib0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1034\/j.1600-0609.2000.90103.x","article-title":"Cytogenetic findings in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic countries","volume":"64","author":"Forestier","year":"2000","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.leukres.2010.09.001_bib0135","first-page":"147","article-title":"Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods","volume":"110","author":"Forestier","year":"2000","journal-title":"For the Nordic Society of Paediatric Haematology and Oncology (NOPHO). Br J Haematol"},{"key":"10.1016\/j.leukres.2010.09.001_bib0140","unstructured":"Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Abberations in Cancer. In: http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman; 2007."},{"issue":"2","key":"10.1016\/j.leukres.2010.09.001_bib0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/leu.2009.251","article-title":"Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia","volume":"24","author":"Schmiegelow","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2010.09.001_bib0150","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ijc.2910560517","article-title":"Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients","volume":"56","author":"Nygren","year":"1994","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2010.09.001_bib0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijc.2910500204","article-title":"Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)","volume":"50","author":"Larsson","year":"1992","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2010.09.001_bib0160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0959-8049(98)00286-X","article-title":"Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic","volume":"35","author":"Fridborg","year":"1999","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2010.09.001_bib0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-0609.2009.01374.x","article-title":"Applicability of IG\/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002\u20132006","volume":"84","author":"Thorn","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2010.09.001_bib0170","unstructured":"Thorn I. Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukemia. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine. Uppsala University: ISBN 978-91-554-7521-5, ISSN 1651-6206, Acta Universitatis Upsaliensis, http:\/\/urn.kb.se\/resolve?urn=urn:nbn:se:uu:diva-101028; 2009."},{"issue":"4","key":"10.1016\/j.leukres.2010.09.001_bib0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2005.03.002","article-title":"Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia","volume":"7","author":"Lugthart","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.leukres.2010.09.001_bib0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V92.1.259.413k21_259_266","article-title":"Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs","volume":"92","author":"Kaspers","year":"1998","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.leukres.2010.09.001_bib0185","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia","volume":"350","author":"Pui","year":"2004","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.leukres.2010.09.001_bib0190","first-page":"624","article-title":"Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia","volume":"9","author":"O\u2019Reilly","year":"1995","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610004479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610004479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T01:47:20Z","timestamp":1592012840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610004479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0145212610004479"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.09.001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}